Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2026-01-22 @ 1:13 AM
Study NCT ID:
NCT01222403
Status:
COMPLETED
Last Update Posted:
2019-06-12
First Post:
2010-10-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older
Sponsor:
Novartis Vaccines
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Influenza | View |
Keywords: